Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.245
+0.006 (2.64%)
May 2, 2024, 4:00 PM EDT - Market closed
Asensus Surgical Revenue
In the year 2023, Asensus Surgical had annual revenue of $8.58M with 21.02% growth. Revenue in the quarter ending December 31, 2023 was $5.43M with 120.41% year-over-year growth.
Revenue (ttm)
$8.58M
Revenue Growth
+21.02%
P/S Ratio
7.61
Revenue / Employee
$41,435
Employees
207
Market Cap
66.64M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.58M | 1.49M | 21.02% |
Dec 31, 2022 | 7.09M | -1.15M | -13.91% |
Dec 31, 2021 | 8.23M | 5.06M | 159.28% |
Dec 31, 2020 | 3.18M | -5.36M | -62.78% |
Dec 31, 2019 | 8.53M | -15.57M | -64.60% |
Dec 31, 2018 | 24.10M | 16.99M | 238.94% |
Dec 31, 2017 | 7.11M | 5.59M | 368.14% |
Dec 31, 2016 | 1.52M | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 401.00K | -1.03M | -71.98% |
Dec 31, 2013 | 1.43M | -684.00K | -32.34% |
Dec 31, 2012 | 2.12M | - | - |
Dec 31, 2011 | 0 | - | - |
Dec 31, 2010 | 0 | - | - |
Dec 31, 2009 | 0 | - | - |
Dec 31, 2008 | 0 | - | - |
Dec 31, 2007 | 0 | - | - |
Dec 31, 2006 | 0 | - | - |
Dec 31, 2005 | 0 | - | - |
Dec 31, 2004 | 0 | - | - |
Dec 31, 2003 | 0 | - | - |
Dec 31, 2002 | 11.77M | -8.65M | -42.34% |
Dec 31, 2001 | 20.42M | -5.56M | -21.40% |
Dec 31, 2000 | 25.97M | 15.73M | 153.62% |
Dec 31, 1999 | 10.24M | -1.71M | -14.34% |
Dec 31, 1998 | 11.96M | -18.30M | -60.49% |
Dec 31, 1997 | 30.26M | 9.35M | 44.75% |
Dec 31, 1996 | 20.90M | 8.79M | 72.62% |
Dec 31, 1995 | 12.11M | 2.38M | 24.42% |
Dec 31, 1994 | 9.73M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Journey Medical | 79.18M |
MDxHealth | 70.19M |
Champions Oncology | 49.22M |
Precision BioSciences | 48.73M |
Pro-Dex | 48.24M |
Cryo-Cell International | 31.37M |
Celularity | 14.79M |
ASXC News
- 3 days ago - Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program - GlobeNewsWire
- 4 weeks ago - Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG - GlobeNewsWire
- 6 weeks ago - Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023 - GlobeNewsWire
- 6 weeks ago - Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024 - GlobeNewsWire
- 2 months ago - Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 2 months ago - Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals - GlobeNewsWire
- 3 months ago - Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program - GlobeNewsWire
- 4 months ago - Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update - GlobeNewsWire